The People's Insurance Company (Group) of China Limited (601319.SS)
CNY 7.38
(-0.54%)
CNY 7.38
(-0.54%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 27.81 Billion CNY | -73.15% |
| 2022 | 32.19 Billion CNY | 34.81% |
| 2021 | 32.05 Billion CNY | 12.97% |
| 2020 | 30.31 Billion CNY | 20.71% |
| 2019 | 27.05 Billion CNY | 1.71% |
| 2018 | 24.44 Billion CNY | -12.6% |
| 2017 | 20.75 Billion CNY | 30.75% |
| 2016 | 17.13 Billion CNY | -26.55% |
| 2015 | 27.3 Billion CNY | 34.38% |
| 2014 | 20.32 Billion CNY | 41.6% |
| 2013 | 23.42 Billion CNY | 23.59% |
| 2012 | 20.11 Billion CNY | 24.23% |
| 2011 | 9.34 Billion CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 21.36 Billion CNY | 7.87% |
| 2024 Q1 | -3.9 Billion CNY | -203.02% |
| 2024 Q2 | -242 Million CNY | 935.65% |
| 2023 Q2 | -4.11 Billion CNY | 16.06% |
| 2023 FY | - CNY | -73.15% |
| 2023 Q3 | -1.16 Billion CNY | 71.71% |
| 2023 Q4 | 2.32 Billion CNY | 300.17% |
| 2023 Q1 | -4.89 Billion CNY | -2432.38% |
| 2022 Q4 | 210 Million CNY | -97.31% |
| 2022 Q1 | -4.06 Billion CNY | -135.54% |
| 2022 Q2 | -4.06 Billion CNY | 0.0% |
| 2022 Q3 | 7.8 Billion CNY | 291.82% |
| 2022 FY | - CNY | 34.81% |
| 2021 Q4 | 11.45 Billion CNY | 219.4% |
| 2021 FY | - CNY | 12.97% |
| 2021 Q1 | -1.39 Billion CNY | -110.73% |
| 2021 Q2 | -1.39 Billion CNY | 0.0% |
| 2021 Q3 | -9.59 Billion CNY | -588.02% |
| 2020 Q1 | -1.04 Billion CNY | -236.38% |
| 2020 FY | - CNY | 20.71% |
| 2020 Q4 | 12.98 Billion CNY | 217.24% |
| 2020 Q2 | -1.04 Billion CNY | 0.0% |
| 2020 Q3 | -11.07 Billion CNY | -959.08% |
| 2019 FY | - CNY | 1.71% |
| 2019 Q3 | 767 Million CNY | 63.02% |
| 2019 Q2 | 470.5 Million CNY | 0.0% |
| 2019 Q1 | 470.5 Million CNY | -64.69% |
| 2019 Q4 | 767 Million CNY | 0.0% |
| 2018 Q3 | 1.33 Billion CNY | 262.3% |
| 2018 Q4 | 1.33 Billion CNY | 0.0% |
| 2018 FY | - CNY | -12.6% |
| 2018 Q1 | -821 Million CNY | -743.92% |
| 2018 Q2 | -821 Million CNY | 0.0% |
| 2017 Q2 | -401 Million CNY | 0.0% |
| 2017 Q1 | -401 Million CNY | -132.14% |
| 2017 FY | - CNY | 30.75% |
| 2017 Q4 | 127.5 Million CNY | 0.0% |
| 2017 Q3 | 127.5 Million CNY | 131.8% |
| 2016 Q4 | 1.24 Billion CNY | 0.0% |
| 2016 Q2 | -860.5 Million CNY | 0.0% |
| 2016 Q1 | -860.5 Million CNY | -12.48% |
| 2016 Q3 | 1.24 Billion CNY | 244.97% |
| 2016 FY | - CNY | -26.55% |
| 2015 Q2 | -2.18 Billion CNY | 0.0% |
| 2015 FY | - CNY | 34.38% |
| 2015 Q4 | -765 Million CNY | 0.0% |
| 2015 Q3 | -765 Million CNY | 64.92% |
| 2015 Q1 | -2.18 Billion CNY | -123.41% |
| 2014 Q4 | -976 Million CNY | 0.0% |
| 2014 FY | - CNY | 41.6% |
| 2014 Q2 | -1.32 Billion CNY | 0.0% |
| 2014 Q3 | -976 Million CNY | 26.17% |
| 2014 Q1 | -1.32 Billion CNY | -13.53% |
| 2013 Q3 | -1.16 Billion CNY | 45.93% |
| 2013 FY | - CNY | 23.59% |
| 2013 Q4 | -1.16 Billion CNY | 0.0% |
| 2013 Q1 | -2.15 Billion CNY | -1341.21% |
| 2013 Q2 | -2.15 Billion CNY | 0.0% |
| 2012 Q3 | 173.5 Million CNY | -92.92% |
| 2012 FY | - CNY | 24.23% |
| 2012 Q1 | 2.45 Billion CNY | 27.81% |
| 2012 Q4 | 173.5 Million CNY | 0.0% |
| 2012 Q2 | 2.45 Billion CNY | 0.0% |
| 2011 Q2 | 1.91 Billion CNY | 0.0% |
| 2011 Q1 | 1.91 Billion CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q4 | 1.91 Billion CNY | 0.0% |
| 2011 Q3 | 1.91 Billion CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|